Growth Boost Series

Anthropic IPO Tranche C — 50% Target Sale

A single-target strategy designed to pursue the sale of up to all allocated reference shares at 150% of the IPO acquisition price

Interested in the Anthropic IPO GrowthBoost Series?

For more information about the available investment strategies, eligibility requirements or participation process, please contact your Candour representative or our Structured Investment team.

We can guide you through the product features, settlement options, key dates and associated risks to help you make an informed investment decision.

Available to eligible Australian resident wholesale investors only.
Contact Us

Single +50% Sale Target | IPO-Linked Equity Exposure | Defined Exit Level

Candour's GrowthBoost Anthropic IPO 50% Target Sale is a short-term Deferred Purchase Agreement providing exposure to Anthropic's proposed Nasdaq listing through a predefined single-target sale strategy.

The structure seeks to sell up to 100% of the initial reference share quantity at a price 50% above the actual IPO acquisition price during the designated Sale Window.

If the target is reached and sales are executed, the realised value contributes to the investor's final settlement entitlement. If the target is not executed, the remaining share exposure continues and is delivered according to the DPA terms.
Single 50% Sale Target

Target sale price set at 150% of the actual IPO acquisition price.

Up to Full Reference Quantity

The strategy may seek to sell up to 100% of the initial reference shares.

Defined Sale Window

Execution is limited to eligible Nasdaq trading sessions from 23–27 November 2026.

Alternative Settlement Options

Physical delivery by default, or an election to receive realised sale value in cash and any remaining exposure in shares.

Continued Exposure if Not Executed

Unexecuted or partially executed reference quantities remain exposed to Anthropic's share price.

How It Works

 

Image 20261112151528 85 33

 
Scenario A – The sale target is executed

If eligible strategy sales are completed, their actual net proceeds become Realised Value.

Under the default settlement, this value is converted into additional delivery shares at the maturity reference price, together with any unsold exposure. Alternatively, a valid cash election allows Realised Value to be paid in AUD while the remaining reference shares are delivered physically.

Scenario B – The target is not executed

If no eligible sales occur, the investor receives the initial reference share quantity through physical delivery, subject to the DPA’s event provisions.

The investor continues to bear exposure to Anthropic’s market price and relevant currency movements.

Product Terms

Reference Asset

Anthropic, PBC Class A Common Stock

Proposed Listing

Nasdaq Global Select Market (ANT)

Subscription Currency

AUD

Investment Term

1 week

Scheduled Issue Date

23 November 2026

Target Price

150% of actual IPO acquisition price

Target Quantity

Up to 100% of initial reference shares

Sale Window

From actual Nasdaq trading commencement, subject to confirmed allocation and broker sale availability, until 1pm New York time on 27 November 2026. Commercially reasonable efforts apply; execution is not guaranteed.

Sale Window Closes

27 November, 1:00 pm New York time

Maturity Date

30 November 2026

Cash Election Deadline

30 November 2026, 5:00 pm Sydney time

Settlement

Shares by default; optional realised-value cash plus remaining shares

Final Settlement

Within 30 Australian Business Days after Maturity, subject to Settlement Disruption

Application Closing Date

Friday 13 November 2026, close of business (Sydney time)

Cleared Funds Deadline

Monday 16 November 2026 (Sydney time)

Issuer

Candour Structured Investment Pty Ltd

Unallocated Cash

Unallocated cash is returned at final settlement with the shares and any elected cash entitlement, after authorised deductions.

Why Consider This Structure
Important Considerations